Indocyanine green-enhanced diode laser treatment of melanoma in a rabbit model.

Indocyanine green (ICG)-enhanced laser therapy was evaluated for the treatment of experimental intraocular melanoma. Immediately after an intravenous injection of ICG, a 790-nm chromophore, 810-nm semiconductor diode laser was used to irradiate Greene hamster melanomas that had been implanted in the iris of rabbits. ICG-enhanced laser treatment of melanoma (14 eyes) was compared with treatment by laser alone (4 eyes), ICG alone (1 eye), and no treatment (2 eyes). Tumors treated with ICG-enhanced laser showed no growth after treatment, as judged by clinical examination and photography. Histologically, 4 of the 14 tumors treated with ICG-enhanced laser showed total necrosis, whereas the remaining 10 tumors treated similarly demonstrated only rare viable cells around blood vessels or at the tumor periphery. Laser treatment without ICG enhancement resulted in only superficial tumor necrosis, and all four of these tumors continued to grow after treatment. With further evaluation, indocyanine green in combination with a commercially available diode laser may be useful in the treatment of ocular melanoma.

Photodynamic therapy of experimental subchoroidal melanoma using chloroaluminum sulfonated phthalocyanine.

Although photodynamic therapy has shown great promise for the treatment of a variety of malignant neoplasms, the role of this new therapeutic modality in the clinical management of intraocular tumors remains incompletely understood. This study examines the effects of photodynamic therapy using chloroaluminum sulfonated phthalocyanine on Greene hamster melanoma transplanted into the subchoroidal space in rabbits. Twenty-four hours after intravenous administration of chloroaluminum sulfonated phthalocyanine (5 mg/kg), tumors were irradiated with 675 nm of light at total light doses of 7 to 60 J/cm2. The results show that tumor growth was arrested at total light doses of 22 to 60 J/cm2. At total light doses of 15 to 21 J/cm2, tumor growth was initially arrested. However, regrowth of these tumors was apparent within 7 days. Total light doses of less than 15 J/cm2 showed no response. Complications of photodynamic therapy, such as intraretinal or subretinal hemorrhages and retinal detachment, were seen only in animals who received total light doses in excess of 43 J/cm2.

Acute ultrastructural changes of cornea after excimer laser ablation.

Corneal ultrastructural changes induced by an argon fluoride excimer laser using different parameters were investigated. Twenty-eight rabbit corneas were ablated at light doses per pulse and repetition rates ranging from 25-800 mJ/cm2 and 1-100 Hz, respectively, at four different total light doses (25-150 J/cm2). Transmission electron microscopy showed that corneal ablations done at subthreshold light doses per pulse with repetition rates higher than 30 Hz and with an exposure more than 100 sec caused significant surface coagulation and an increase in pseudomembrane thickness. These changes were not observed in ablations done above threshold light doses per pulse, regardless of repetition rate and exposure time. However, repetition rates as high as 80 Hz caused damage to the endothelium and Descemet's membrane at the same ablation depth that did not cause such damage using repetition rates under 40 Hz. It appears that high repetition rates used during excimer laser corneal surgery may cause irreversible damage to the cornea.

Ab-interno neodymium:YAG versus erbium:YAG laser sclerostomies in a rabbit model.

This study was undertaken to determine whether thermally-induced tissue necrosis was a factor in ab-interno contact-laser sclerostomy failure. A rabbit model was used to compare the continuous-wave Neodymium (Nd):YAG with the pulsed Erbium (Er):YAG laser with respect to such failure. Laser energy was focused into a fused-silica fiber optic (400 microns) for the Nd:YAG laser (12 W; 3 to 5 seconds), and into a single-crystal, uncladded sapphire fiber optic (250 microns) for the Er:YAG laser (7 to 8 mJ; 250 microseconds; 6 to 8 pulses). The Nd:YAG and Er:YAG lasers required from 21 to 35 J and from 42 to 64 mJ, respectively, to create the sclerostomies. Filtering blebs and intraocular pressure reduction lasted longer (log-rank test; P less than .03) and surgical complications were fewer in the Er:YAG group than in the Nd:YAG group. By creating sclerostomies with minimal thermal damage, the Er:YAG laser may offer significant clinical advantages over lasers producing larger thermal effects.

Subretinal perfluorocarbon liquids. An experimental study.

Perfluorocarbon liquids (PFCL) are fully fluorinated, synthetic, transparent compounds with a high specific gravity. These compounds are being increasingly used as an intraoperative tool for repair of complicated retinal detachments. A known complication of their use, however, is liquid entering the subretinal space via a retinal break. The purpose of this study was to evaluate the effects of two of these liquids when placed subretinally in the rabbit eye. Vitrectomy, retinotomy, and subretinal injection of 0.03 cc of either perfluoroctane, perfluorotributylamine, or balanced salt solution (control eyes) were performed on 36 rabbit eyes. Animals were monitored clinically by indirect ophthalmoscopy and fundus photography for up to 21 days. After the 21-day observation period, electroretinograms (ERG) were taken before the rabbits were killed. Histopathologic studies were done at 3 hours, 24 hours, 3 days, 7 days, 14 days, and 21 days after injection. Three eyes demonstrated tearing of the retinotomy site due to downward migration of the PFCL droplet. Results of the ERGs were normal in all animals tested. Phagocytosis of PFCL droplets by the retinal pigment epithelium (RPE) was observed in 1 eye 3 hours after injection. Three of the eyes that received PFCL injections and all of the control eyes demonstrated moderate intracellular edema of both inner and outer nuclear layers as early as 24 hours after injection. In one eye injected with PFCL, these changes progressed to swelling and cystic formation of the inner nuclear layer and mild degeneration of the outer photoreceptor segments 3 days after injection. It was assumed that these effects occurred on a mechanical basis and were not related to PFCL toxicity.(ABSTRACT TRUNCATED AT 250 WORDS)

Infrared laser sclerostomies.

Four solid-state lasers with three fiberoptic delivery systems were used to perform laser sclerostomies in an acute-injury rabbit model and in fresh human globes. The lasers used were continuous-wave neodymium:yttrium aluminum garnet (YAG, 1.06 microns) and pulsed holmium:yttrium scandium galliam garnet (YSGG) (2.10 microns), erbium:YSGG (2.79 microns), and erbium:YAG (2.94 microns). Thermal damage to tissue and total laser energy required to produce sclerostomies decreased with increasing wavelength. In human tissue using a 600-microns fused silica fiberoptic, maximum thermal damage (greater than or equal to 100 microns) was noted at 1.06 microns with a total energy of 21 J at a power density of 2.5 kW/cm2. In addition, focal damage to the iris and ciliary body was noted at this wavelength. The least amount of thermal damage (15-20 microns) and lowest total energies needed were found at 2.94 microns. A 250-microseconds pulse length and pulse radiant exposures of 3.6 J/cm2 and 14.3 J/cm2 were used for the low hydroxyl-fused silica (500 microns) and zirconium fluoride (250 microns) fiberoptics, respectively. Although zirconium fluoride fibers have high through-put efficiencies that facilitate study of laser tissue interactions at 2.94 microns, problems encountered with fragility and solubility of the bare tip in aqueous media limit its usefulness. A high attenuation rate with the low hydroxyl-fused silica fiber limited its usable length to 35 cm at 2.94 microns. Tissue damage during sclerostomy formation was minimized at 2.94 microns, reaching a maximum at 1.06 microns. Minimizing tissue damage theoretically could decrease subconjunctival scarring and filtration failure.(ABSTRACT TRUNCATED AT 250 WORDS)

Laser trabecular ablation (LTA).

As part of a pilot study for glaucoma surgery, the use of 3 infrared solid state lasers with 4 fiber optic delivery systems to ablate human trabecular meshwork was investigated. Laser trabecular ablation (LTA) was attempted with the Erbium:YAG (2.94 microns), Erbium:YSGG (2.79 microns), and Holmium:YSGG (2.1 microns) lasers. Laser energy was delivered as a single pulse (250 microseconds) by tissue fiber optic contact with low hydroxyl-fused silica (200 and 500 microns), zirconium fluoride (250 microns), or sapphire (250 microns) fiber optics. Total energy required and thermal effects decreased as laser wavelength increased. LTA was best achieved at 2.94 microns (4 mJ total energy; energy densities = 8.2-12.7 J/cm2; pulse length 250 microseconds) with average thermal damage zones of 5.3-10.3 +/- 1.3-2.4 microns (means +/- SDs) to contiguous structures. This finding has potential applications in the surgical treatment of open-angle and congenital glaucoma and may minimize failure rates seen in other types of surgery on the trabecular meshwork where disrupted trabecular meshwork is not removed.